Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - Netherlands

Netherlands

In the year 2024, the Digestives & Intestinal Remedies market market in the Netherlands generated a revenue of €64.06m.
It is projected to experience an annual growth rate of 1.43% (CAGR 2024-2029).
When compared globally, in China stands as the country with the highest revenue, amounting to €4,087.00m in 2024.
Taking into account the population figures, the per person revenue in the Netherlands for 2024 is €3.63.
The Netherlands has seen a growing demand for probiotics and natural remedies in the Digestives & Intestinal Remedies market.

Key regions: Brazil, India, United Kingdom, Germany, China

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Digestives & Intestinal Remedies market in Netherlands has been experiencing steady growth in recent years. Customer preferences in the Digestives & Intestinal Remedies market in Netherlands are driven by a growing awareness of the importance of digestive health and an increasing demand for natural and organic products. Consumers in Netherlands are becoming more conscious about their overall health and are looking for products that can help improve their digestive system. As a result, there is a growing preference for digestive remedies that are made from natural ingredients and do not contain artificial additives or preservatives. Trends in the Digestives & Intestinal Remedies market in Netherlands include the rising popularity of probiotics and prebiotics. Probiotics are live bacteria and yeasts that are good for digestive health, while prebiotics are non-digestible fibers that promote the growth of beneficial bacteria in the gut. These products are gaining traction as consumers become more aware of the role of gut health in overall well-being. In addition, there is a growing demand for digestive remedies that are specifically formulated for different age groups, such as infants, children, and the elderly.Local special circumstances in the Digestives & Intestinal Remedies market in Netherlands include the country's high healthcare standards and strict regulations. Netherlands has a well-developed healthcare system, which includes a strong emphasis on preventive care. This has led to a high level of consumer awareness and demand for products that can help maintain digestive health. Furthermore, the Dutch government has implemented regulations to ensure the safety and efficacy of healthcare products, including digestive remedies. This provides consumers with confidence in the quality of the products available in the market.Underlying macroeconomic factors that contribute to the growth of the Digestives & Intestinal Remedies market in Netherlands include the country's strong economy and high disposable income levels. Netherlands has a prosperous economy, with a high GDP per capita and low unemployment rate. This enables consumers to afford premium products, including digestive remedies. In addition, the aging population in Netherlands is driving the demand for healthcare products and services, including those that cater to digestive health.Overall, the Digestives & Intestinal Remedies market in Netherlands is developing in response to customer preferences for natural and organic products, as well as the growing awareness of the importance of digestive health. The rising popularity of probiotics and prebiotics, as well as the demand for age-specific digestive remedies, are key trends in the market. The country's high healthcare standards, strict regulations, strong economy, and high disposable income levels are also contributing factors to the market's growth.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.